Stocks
Ocugen, Inc.OCGN
NASDAQHealthcareBiotechnology$2.48+5.98%
Focused on developing gene therapies and vaccines, this biopharmaceutical company specializes in treatments for blindness diseases and infectious diseases. Investors closely monitor its pipeline progress and partnerships, particularly its collaboration on COVID-19 vaccine development.
Market Cap: $813.2M52W Range: $0.52 – $2.67
Congressional Interest in Ocugen, Inc. (OCGN)
1 member of Congress has disclosed 2 trades in Ocugen, Inc. (OCGN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading OCGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-06-16 | Christopher L. Jacobs | buy | $15K – $50K |